Yousif Capital Management LLC Has $1.50 Million Position in Integer Holdings Co. (NYSE:ITGR)

Yousif Capital Management LLC lessened its stake in shares of Integer Holdings Co. (NYSE:ITGR) by 2.1% in the first quarter, according to the company in its most recent filing with the SEC. The fund owned 12,678 shares of the medical equipment provider’s stock after selling 268 shares during the quarter. Yousif Capital Management LLC’s holdings in Integer were worth $1,496,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Capital Research Global Investors raised its position in shares of Integer by 16.0% in the 4th quarter. Capital Research Global Investors now owns 1,410,803 shares of the medical equipment provider’s stock valued at $186,960,000 after buying an additional 194,895 shares in the last quarter. Loomis Sayles & Co. L P lifted its stake in shares of Integer by 3.8% in the fourth quarter. Loomis Sayles & Co. L P now owns 558,715 shares of the medical equipment provider’s stock valued at $74,041,000 after buying an additional 20,688 shares in the last quarter. Congress Asset Management Co. lifted its stake in shares of Integer by 4.9% in the first quarter. Congress Asset Management Co. now owns 522,656 shares of the medical equipment provider’s stock valued at $61,679,000 after buying an additional 24,306 shares in the last quarter. Driehaus Capital Management LLC lifted its stake in shares of Integer by 5.5% in the fourth quarter. Driehaus Capital Management LLC now owns 451,464 shares of the medical equipment provider’s stock valued at $59,828,000 after buying an additional 23,706 shares in the last quarter. Finally, Northern Trust Corp lifted its position in shares of Integer by 14.2% during the fourth quarter. Northern Trust Corp now owns 422,380 shares of the medical equipment provider’s stock valued at $55,974,000 after purchasing an additional 52,556 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

Insider Transactions at Integer

In other Integer news, CEO Joseph W. Dziedzic sold 338,975 shares of the company’s stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the transaction, the chief executive officer now owns 47,000 shares in the company, valued at approximately $5,788,990. This represents a 87.82% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Donald J. Spence sold 14,739 shares of the stock in a transaction that occurred on Wednesday, June 4th. The stock was sold at an average price of $120.38, for a total transaction of $1,774,280.82. Following the completion of the transaction, the director now owns 18,781 shares in the company, valued at $2,260,856.78. This trade represents a 43.97% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 362,434 shares of company stock valued at $44,577,115 in the last three months. 2.16% of the stock is currently owned by company insiders.

Integer Trading Up 0.1%

NYSE:ITGR opened at $118.46 on Tuesday. The company has a fifty day moving average of $119.67 and a 200 day moving average of $127.19. Integer Holdings Co. has a 52 week low of $104.93 and a 52 week high of $146.36. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. The firm has a market capitalization of $4.13 billion, a P/E ratio of 35.26, a P/E/G ratio of 1.72 and a beta of 0.98.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. The business had revenue of $437.39 million for the quarter, compared to the consensus estimate of $428.51 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. The company’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.14 EPS. On average, research analysts predict that Integer Holdings Co. will post 6.01 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts have commented on ITGR shares. KeyCorp lowered their price objective on shares of Integer from $154.00 to $145.00 and set an “overweight” rating on the stock in a research report on Monday, April 21st. Oppenheimer downgraded shares of Integer from an “outperform” rating to a “market perform” rating in a research note on Friday, February 21st. Benchmark reduced their price objective on shares of Integer from $150.00 to $140.00 and set a “buy” rating for the company in a research note on Friday, April 25th. Wall Street Zen raised shares of Integer from a “sell” rating to a “hold” rating in a research note on Monday, May 19th. Finally, Citigroup raised shares of Integer from a “hold” rating to a “strong-buy” rating and boosted their price target for the stock from $133.00 to $140.00 in a research note on Thursday, May 22nd. Two equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Integer has a consensus rating of “Moderate Buy” and a consensus price target of $145.00.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.